Revance Therapeutics, Inc. (RVNC) financial statements (2022 and earlier)

Company profile

Business Address 1222 DEMONBREUN STREET
NASHVILLE, TN 37203
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:225437290176283186252
Cash and cash equivalents1113341717328364202
Short-term investments114103119103 12251
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)(0)0(0) 
Restricted cash and investments      0
Receivables32 27000
Inventory, net of allowances, customer advances and progress billings106     
Inventory106     
Prepaid expense    211
Other current assets    000
Other undisclosed current assets8675(0)6 
Total current assets:246450297208285193254
Noncurrent Assets
Operating lease, right-of-use asset443027
Property, plant and equipment2517151491120
Long-term investments and receivables      2
Long-term investments      2
Intangible assets, net (including goodwill), including:5571     
Goodwill147147     
Intangible assets, net (excluding goodwill)5571     
Other undisclosed intangible assets, net (including goodwill)(147)(147)     
Restricted cash and investments5311110
Other noncurrent assets912311 
Other undisclosed noncurrent assets147147     
Total noncurrent assets:2852704418101222
TOTAL ASSETS:531720340226296204276
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5046272319169
Accounts payable111388743
Accrued liabilities4033191512126
Deferred revenue988
Debt  3    
Derivative instruments and hedges, liabilities333    
Contract with customer, liability9
Other undisclosed current liabilities54  233
Total current liabilities:67614132212012
Noncurrent Liabilities
Long-term debt and lease obligation32020826    
Long-term debt, excluding current maturities281181     
Operating lease, liability392726
Liabilities, other than long-term debt76774849665
Deferred revenue and credits344
Deferred revenue747748
Contract with customer, liability43
Deferred rent credit   3
Other liabilities1    0 
Derivative instruments and hedges, liabilities   3321
Other undisclosed noncurrent liabilities     25
Total noncurrent liabilities:39528574496811
Total liabilities:46334611581272723
Stockholders' equity
Stockholders' equity attributable to parent68374225146269177253
Common stock0000000
Additional paid in capital1,4661,5011,070830811599586
Accumulated other comprehensive income (loss)(0) 0(0) (0)(0)
Accumulated deficit(1,398)(1,126)(844)(685)(542)(422)(332)
Total stockholders' equity:68374225146269177253
TOTAL LIABILITIES AND EQUITY:531720340226296204276

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues781504000
Cost of revenue(14)(6)  (0)(0)(0)
Cost of goods and services sold(14)(6)     
Financial services costs(0)(0)(0)
Gross profit:64904(0)(0)(0)
Operating expenses(352)(288)(165)(146)(121)(89)(73)
Other undisclosed operating income146  000
Operating loss:(275)(273)(164)(143)(120)(88)(72)
Nonoperating income (expense)(0)45311(0)
Investment income, nonoperating0464110
Other nonoperating expense(1)(1)(0)(1)(1)(1)(0)
Interest and debt expense(6)(15) (0)(0)(1)(1)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (1)  
Loss from continuing operations before income taxes:(281)(285)(159)(139)(121)(89)(74)
Income tax expense (benefit) 3 (3)   
Net loss:(281)(282)(159)(142)(121)(89)(74)
Other undisclosed net income (loss) attributable to parent0(0)(0)(0) (1)0
Net loss available to common stockholders, diluted:(281)(282)(159)(143)(121)(89)(73)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(281)(282)(159)(142)(121)(89)(74)
Comprehensive loss:(281)(282)(159)(142)(121)(89)(74)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)(0)0(1)0
Comprehensive loss, net of tax, attributable to parent:(281)(282)(159)(143)(121)(89)(74)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: